004720 — PharmGen Science Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapNeutral

Annual cashflow statement for PharmGen Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	41,949	89,960	7,991	1,017	-116,641
Depreciation
Amortisation
Non-Cash Items	-39,514	-80,051	-4,065	12,552	125,385
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	2,241	-14,522	-2,688	-15,776	-7,938
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	7,784	-1,286	5,439	2,384	5,322
Capital Expenditures	-34,010	-11,956	-3,292	-2,784	-2,671
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	3,625	-3,328	6,552	1,894	249
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-30,385	-15,284	3,260	-889	-2,423
Financing Cash Flow Items	-176	1,803	297	270	226
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities	30,340	2,269	8,852	-484	-18,935
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	7,739	-14,302	17,551	1,011	-16,036